HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jun Nakajima Akira Furuse Tadasu Kohno Toshiya Ohtsuka Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakajima, J. Articles by Ohtsuka, T. Search for Related Content PubMed PubMed Citation Articles by Nakajima, J. Articles by Ohtsuka, T. Related Collections Related Article

Ann Thorac Surg 1996;61:158-162
© 1996 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Excellent Survival in a Subgroup of Patients With Intrapulmonary Metastasis of Lung Cancer

Departments of Cardiothoracic Surgery and Pathology, Faculty of Medicine, University of Tokyo, Tokyo, Japan

Accepted for publication June 30, 1995.

Background. Recently, intrapulmonary metastases in non-small cell lung cancer have been considered to have less influence on prognosis than extrapulmonary metastases. We report a subgroup found among patients with intrapulmonary metastases showing a good prognosis.

Methods. A retrospective study was performed on 236 consecutive patients with non-small cell lung cancer who underwent surgical resection of their tumors. Intrapulmonary metastases were found histopathologically in 50 of them, and their clinicopathologic features were investigated.

Results. Analysis of postsurgical results revealed a subgroup of patients showing excellent prognosis (n = 15). They had well-differentiated adenocarcinomas with bronchioloalveolar spread and pT1-2 N0, without vascular or lymphangitic invasion. Their actuarial 5-year survival rate was 100%, with a mean survival interval to date of 28 months. However, none of the other 35 patients survived for 5 years, with a mean survival interval to date of 11 months.

Conclusions. We have clarified that patients with histopathologically diagnosed intrapulmonary metastases from non-small cell lung cancer do not constitute a homogeneous group. Pulmonary metastases with good prognosis, which are considered to be hematogenous metastases, may be benign lesions such as adenomatous or atypical adenomatous hyperplasias mimicking malignant tumors.

Related Article

Invited Commentary

Samuel P. Hammar
Ann. Thorac. Surg. 1996 61: 162-163. [Extract] [Full Text]

This article has been cited by other articles:

				H. Rostad, T.-E. Strand, A. Naalsund, and J. Norstein Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Ann. Thorac. Surg., January 1, 2008; 85(1): 204 - 209. [Abstract] [Full Text] [PDF]

				D. Arenberg Bronchioloalveolar Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 306S - 313S. [Abstract] [Full Text] [PDF]

				J. L. Port, R. J. Korst, P. C. Lee, A. L. Kansler, Y. Kerem, and N. K. Altorki Surgical Resection for Multifocal (T4) Non-Small Cell Lung Cancer: Is the T4 Designation Valid? Ann. Thorac. Surg., February 1, 2007; 83(2): 397 - 400. [Abstract] [Full Text] [PDF]

				T. Nakagawa, N. Okumura, K. Miyoshi, T. Matsuoka, and K. Kameyama Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 635 - 639. [Abstract] [Full Text] [PDF]

				Y.-W. Tung, C.-P. Hsu, S.-E. Shai, J.-Y. Hsia, S.-S. Yang, and C.-Y. Chen Surgical feasibility of ipsilateral multifocal non-small cell lung cancer in different lobes: excellent survival in node-negative subgroup Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1008 - 1012. [Abstract] [Full Text] [PDF]

				P. F. Roberts, M. Straznicka, P. N. Lara, D. H. Lau, D. M. Follette, D. R. Gandara, and J. R. Benfield Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1597 - 1601. [Abstract] [Full Text] [PDF]

				J. Furak, I. Trojan, T. Szoke, L. Tiszlavicz, Z. Morvay, J. Eller, and A. Balogh Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 818 - 823. [Abstract] [Full Text] [PDF]

				M. Th. M. van Rens, P. Zanen, A. Brutel de la Riviere, H. R. J. Elbers, H. A. van Swieten, and J. M. M. van den Bosch Survival in Synchronous vs Single Lung Cancer : Upstaging Better Reflects Prognosis Chest, October 1, 2000; 118(4): 952 - 958. [Abstract] [Full Text] [PDF]

				M. Kamiyoshihara, O. Kawashima, S. Sakata, S. Ishikawa, Y. Morishita, M. Kamiyoshihara, O. Kawashima, S. Sakata, S. Ishikawa, and Y. Morishita Non-Small Cell Lung Cancer With Ipsilateral Intrapulmonary Metastasis Asian Cardiovasc Thorac Ann, June 1, 2000; 8(2): 141 - 145. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and R. Nakai Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis Ann. Thorac. Surg., August 1, 1999; 68(2): 326 - 330. [Abstract] [Full Text] [PDF]

				I. Yoshino, R. Nakanishi, T. Osaki, S. Hasuda, S. Taga, M. Takenoyama, T. Yoshimatsu, and K. Yasumoto Postoperative Prognosis in Patients With Non-Small Cell Lung Cancer With Synchronous Ipsilateral Intrapulmonary Metastasis Ann. Thorac. Surg., September 1, 1997; 64(3): 809 - 813. [Abstract] [Full Text]